Robert Spurr

CIK 1543795 · View on SEC EDGAR ↗

Insider

First SEC filing: June 1, 2020 · Latest: June 1, 2020

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 24 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

24 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
April 14, 2022 BHC S 10b5-1 1,595 $22.19 $35,393 90,506 Direct -1.73% Disposed -68.3% (price as of 2026-08-19)
March 15, 2022 BHC S 10b5-1 4,846 $22.20 $107,581 92,101 Direct -5.00% Disposed -68.4% (price as of 2026-08-19)
March 2, 2022 BHC S 10b5-1 1,595 $23.37 $37,275 65,394 Direct -2.38% Disposed -69.9% (price as of 2026-08-19)
Feb. 15, 2022 BHC S 10b5-1 3,251 $25.02 $81,340 60,299 Direct -5.12% Disposed -71.9% (price as of 2026-08-19)
Jan. 18, 2022 BHC S 10b5-1 3,251 $26.63 $86,574 63,550 Direct -4.87% Disposed -73.6% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) May 10, 2022 13,592 Disposed
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (13,592) May 10, 2022 13,592 Acquired
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) May 10, 2022 8,643 Disposed
May 10, 2022 BHC Restricted Share Units Common Shares, No Par Value (8,643) May 10, 2022 8,643 Acquired
March 2, 2022 BHC Non-Qualified Stock Options (right to purchase) Common Shares, No Par Value (131,910) $24.17 March 2, 2032 131,910 Acquired
Feb. 27, 2022 BHC Restricted Share Units Common Shares, No Par Value (0) $24.35 Feb. 27, 2022 15,615 Disposed
Feb. 27, 2022 BHC Restricted Share Units Common Shares, No Par Value (15,615) Feb. 27, 2022 15,615 Acquired
Sept. 1, 2021 BHC Non-Qualified Stock Options (right to purchase) Common Shares, No Par Value (31,400) $28.85 Sept. 1, 2031 31,400 Acquired
March 3, 2021 BHC Non-qualified Stock Options (right To Purchase) Common Shares, No Par Value (32,749) $32.56 March 3, 2031 32,749 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 1, 2020 BHC Common Shares, No Par Value Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (30,576) 30,576 Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (39,863) 39,863 Direct
June 1, 2020 BHC Non-qualified Stock Options (right To Purchase)→ Common Shares, No Par Value (56,858) 56,858 Direct
March 12, 2012 RGEN Common Stock 10,000 Direct
March 12, 2012 RGEN Stock Option (Right to Purchase)→ Common Stock (100,000) 100,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BHC

President US Pharmaceutical Business
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $336,538 $861,105 $874,563 $2,230,891 $4,303,097
2021 $636,154 $821,200 $18,050 $3,868,624

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.